Zobrazeno 1 - 6
of 6
pro vyhledávání: '"Nahed Mohamed Sallam"'
Autor:
El-Sayed Khafagy, Amr S. Abu Lila, Nahed Mohamed Sallam, Rania Abdel-Basset Sanad, Mahgoub Mohamed Ahmed, Mamdouh Mostafa Ghorab, Hadil Faris Alotaibi, Ahmed Alalaiwe, Mohammed F. Aldawsari, Saad M. Alshahrani, Abdullah Alshetaili, Bjad K. Almutairy, Ahmed Al Saqr, Shadeed Gad
Publikováno v:
Gels, Vol 8, Iss 4, p 235 (2022)
Carvedilol (CRV) is a non-selective third generation beta-blocker used to treat hypertension, congestive heart failure and angina pectoris. Oral administration of CRV showed poor bioavailability (25%), which might be ascribed to its extensive first-p
Externí odkaz:
https://doaj.org/article/5a08d724a47c40cd83aa21f30b0e9139
Autor:
Shadeed Gad, Nahed Mohamed Sallam, Mahgoub Mohamed Ahmed, El-Sayed Khafagy, Mamdouh Ghourab, Rania Abdel-Basset Sanad
Publikováno v:
Records of Pharmaceutical and Biomedical Sciences. 5:40-51
In this article, we offer a summary of a broad variety of colloidal drug delivery systems with a special emphasis on vesicular used in testing or theoretically useful as carrier systems for medicines or active biomolecules or as cell carriers with th
Autor:
Nahed Mohamed Sallam, EL Sayed Abdu Khafagy, Mamdouh M. Ghorab, Mahgoub Mohamed Ahmed, Rania Abdel-Basset Sanad, Shadeed Gad
Publikováno v:
Drug Delivery and Translational Research. 11:1009-1036
The purpose of this investigation was to encapsulate carvedilol, a model beta-blocker antihypertensive into nano-spanlastics, followed by incorporation into 1% CMC wafer to afford a mucoadhesive buccal drug delivery system, targeting to sidestep the
Autor:
Mamdouh M. Ghorab, Rania Abdel-Basset Sanad, Nahed Mohamed Sallam, Mahgoub Mohamed Ahmed, EL Sayed Abdu Khafagy, Shadeed Gad
Purpose: Carvedilol (CRV) is a non-selective beta-blocker used for hypertension treatment, angina pectoris, and heart failure. Oral administration of CRV showed poor bioavailability (25%), which may be due to exposure to the first-pass metabolism. Bu
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::195f311eacc71f71e5d770c14b869c71
https://doi.org/10.21203/rs.3.rs-268464/v1
https://doi.org/10.21203/rs.3.rs-268464/v1
Autor:
Rania Abdel-Basset Sanad, Mokhles Abdel Fadil Zineldin, Rasha Mohamed Kharshoum, Nahed Mohamed Sallam
Publikováno v:
Journal of Drug Delivery Science and Technology. 41:78-89
Salbutamol Sulphate (SS) as a model bronchodilator drug undergoes first pass metabolism in liver, which has an oral bioavailability of only 50% of the administrated dose. Thus, the aim of this study was to attain rapid absorption and improved bioavai
Autor:
Nahed Mohamed Sallam, Rasha Mohamed kharshoom, Rania Abdel-Basset Sanad, Mokhles Abdelfadil Zeneldin
Publikováno v:
Current drug delivery. 14(4)
Background: Salbutamol sulphate (SS) is a model short-acting β2-adrenergic receptor agonist used for the relief of bronchospasm having poor bioavailability (50%) due to its extensive first-pass effect. Objective: Formulation of SS as fast dissolving